Navigation Links
Amedica's Silicon Nitride Ceramic Bearing Technology Receives Prestigious HAP Paul Award for Use in Total Hip Arthroplasty
Date:10/10/2007

SALT LAKE CITY, Oct. 10 /PRNewswire/ -- Amedica Corporation, an orthopedic implants company focused on silicon nitride ceramic technologies, announced today that a paper it presented on the in-vitro testing and evaluation of its silicon nitride ceramic bearings for total hip arthroplasty won the HAP Paul Award from the International Society for Technology in Arthroplasty (ISTA). The prestigious HAP Paul Award, which was presented to Amedica at ISTA's 20th Annual Congress, held October 4 - 6, 2007, in Paris, France, is given for outstanding research in new technology for joint replacements.

The award-winning research paper, "In Vitro Performance of Silicon Nitride Ceramic in Total Hip Bearings," will be published by ISTA as a special article in the Journal of Arthroplasty. The paper demonstrates that Amedica's MC2(TM) silicon nitride based ceramic bearings, being developed for reconstructive hip, knee and spine implants, have the combination of strength, toughness and wear resistance characteristics that may overcome the limitations of currently available bearings.

The paper was authored by a team led by Ashok Khandkar, Ph.D., and included B. Sonny Bal, MD, University of Missouri, Columbia; Dr. Aaron A. Hofmann MD; University of Utah; Dr. Ian C. Clarke, Ph.D., Loma Linda University; Dr. Alan Lakshminarayanan, Ph.D., Amedica; and Mohamed N. Rahaman, Ph.D., University of Missouri-Rolla.

The team of collaborators compared the fracture strength and in-vitro wear characteristics using hip simulators of Amedica's Micro-composite Ceramic, or MC2, bearings with current state-of-the-art bearings. The data presented at ISTA's Annual Congress demonstrated that the silicon nitride femoral heads had substantially greater burst strength than similar 28 mm femoral heads made using the strongest commercially available ceramic.

"We are delighted and honored to win the HAP Paul Award for our work," said Ashok Khandkar, Ph.D., CEO of Amedica Corporation. "This paper demonstrates the inherent strength and wear resistance advantages of silicon nitride ceramics compared with the current generation of ceramic orthopedic implants. We are pleased that a group of our peers has selected our research on silicon nitride ceramic and recognized the important potential of this material for total hip arthroplasty. Importantly, we believe independent recognition such as this award, will increase awareness of silicon nitride and support its future use in orthopedic applications such as ceramic bearings for joint replacement."

About Amedica

Amedica Corporation is an emerging orthopedic implants company focused on using its ceramics technologies to develop and commercialize a broad range of innovative, high-performance spine and joint implants for the growing orthopedic device market. Its products under development include reconstructive spine, hip and knee implants that may represent a new standard of care in total joint implants based on superior durability, performance and safety.

Contact:

Ashok C. Khandkar

Chief Executive Officer

(801) 583-5100

Email: ak@amedicacorp.com

http://www.amedicacorp.com


'/>"/>
SOURCE Amedica Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Silicon eye implants
2. Artificial silicon retina
3. Implantable devices to be powered by organosilicon compounds in the future
4. Silicone Rubber Flap Restore Speech
5. Silicone Implants Make No Significant Difference To Breast Cancer Survivors
6. Potentially Dangerous levels of Platinum Found in Women with Silicone Gel Breast Implants
7. Silicone Leaks Seen Among Women with Breast Implants
8. Canadian Regulators allow Silicone Breast Implants in Market
9. FDA gives the green signal for silicone breast implants
10. School atmosphere have some bearing on bad habits in children
11. Vitamin B: Vital for Women During Child-bearing Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: